Diagnostic Imaging Centres in the UK: Market Size, Businesses & Forecast 2026

The diagnostic imaging centres industry in the UK comprises facilities providing critical medical scanning services, including MRI, CT, ultrasound, and X-ray modalities, to both public and private patients. The sector is heavily integrated with the National Health Service (NHS), which increasingly relies on independent sector providers to deliver diagnostic tests amid national backlog reduction efforts. The industry is experiencing steady structural evolution driven by the rollout of Community Diagnostic Centres (CDCs) and digital standard updates like the Diagnostic Imaging Data Set (DIDS) version 2.0 mandated by 2026.

Industry snapshot

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Diagnostic Imaging Centres in the UK industry cover?

This industry encompasses dedicated facilities, standalone diagnostic centres, and mobile units that perform medical imaging procedures to help diagnose, monitor, or treat diseases. Services span non-ionising techniques such as Magnetic Resonance Imaging (MRI) and ultrasound, alongside ionising technologies like Computed Tomography (CT), X-rays, and Positron Emission Tomography (PET-CT). Providers operate as either fully private entities or contracted independent sector partners integrated within public healthcare delivery.

• •Primary modalities include MRI, CT, ultrasound, plain-film X-ray, and mammography.
• •Scope includes both static community facilities and mobile scanning units deployed to alleviate localized healthcare bottlenecks.
• •Operational parameters are heavily governed by the National Health Service (NHS) clinical referral pathways.

Who operates in the industry and how is it structured?

The UK market is structured around a public-private hybrid model where the NHS acts as the largest single purchaser of diagnostic services. Independent sector providers deliver a substantial portion of community-based and outsourced diagnostic scans under central framework agreements. Real estate footprint consists of independent clinics, hospital-based outsourced units, and expanding regional hubs designated as Community Diagnostic Centres (CDCs).

• •Operators contract via national procurement vehicles like the £10 billion NHS Increasing Capacity Framework Agreement.
• •The national network incorporates over 160 planned or operational Community Diagnostic Centres funded by public capital.
• •Providers routinely utilize Managed Equipment Services (MES) partnerships with medical technology manufacturers to maintain infrastructure.

What drives demand in the industry?

Demand is primarily driven by the long-term clinical backlogs facing the NHS, alongside an aging UK population suffering from a rising prevalence of chronic conditions like oncology and cardiology disorders. Government funding injections aimed at expanding diagnostic capacity directly translate to elevated procurement activity and outsourced scan volumes. Furthermore, the growth of the private medical insurance (PMI) sector and direct self-pay patients creates supplementary retail demand channels.

• •Expanding clinical needs stem from cardiovascular, oncological, and orthopedic diagnostic pathways.
• •The UK government allocated dedicated capital under the multi-billion pound CDC program to finance millions of incremental tests annually.
• •Rising referral rates from general practitioners (GPs) seeking direct-access diagnostic workflows speed up community throughput.

Who are the notable companies in the industry?

The competitive landscape features a mix of large-scale corporate providers, teleradiology specialists, and global medical technology suppliers delivering managed services. Leading independent operators heavily compete for NHS regional contracts and private patient market share by expanding geographic reach and technology portfolios. While several major operating entities function as specialized private corporations or subsidiaries, the broader market is influenced by major multinational public medical technology companies providing systems and clinical partnerships.

• •InHealth Group operates as a prominent private provider, running 22 Community Diagnostic Centres and securing major regional direct-access imaging contracts by 2026.
• •Alliance Medical Limited is a key independent provider of MRI and PET-CT services, operating static and mobile clinics across the UK.
• •Sonic Healthcare UK (incorporating The Doctors Laboratory) provides extensive clinical diagnostic capabilities across key urban bases.
• •Siemens Healthcare Limited (Siemens Healthineers) acts as a vital public manufacturer and partner, introducing advanced hybrid systems like the MAGNETOM Flow Elite and mobile CT units to the UK market in 2026.

What are the recent trends and outlook?

The industry is pivoting toward digitized, interconnected platforms and community-centric care models to maximize diagnostic throughput. The deployment of Artificial Intelligence (AI) workflow tools is accelerating image analysis and helping operators address widespread staff shortages. Additionally, national digital initiatives are unifying the sharing of diagnostic outputs across traditional public and private organizational borders.

• •The NHS England National Imaging Registry (NIR) establishes a standards-based digital infrastructure for real-time, federated access to patient imaging history.
• •AI integration is targeting a reduction in reporting backlogs, helping mitigate the impact of an estimated 30% national radiologist vacancy rate.
• •Managed replacement cycles are increasingly focusing on sustainable, hybrid-powered relocatable and mobile imaging assets.

How is the industry regulated?

Operators are subject to strict clinical, quality, and data governance standards managed by UK health authorities. Independent facilities must achieve and maintain registration with national care regulators to validate clinical safety and hygiene standards. Furthermore, data collection methodologies face strict compliance deadlines to align local radiology systems with standardized national reporting registries.

• •All commercial and clinical diagnostic facilities must be registered and inspected by the Care Quality Commission (CQC) in England.
• •Providers must conform to the updated Diagnostic Imaging Data Set (DIDS) version 2.0 information standard (DAPB1577 Amd 25/2025).
• •Full mandatory data conformance for all directly provided or commissioned NHS imaging diagnostic tests is required by October 30, 2026.

Government, statistical and trade sources used for this Claight analysis.

• NHS England Digital - Diagnostic Imaging Data Set (DIDS) 2025-2026 ·
• GOV.UK - NHS England Diagnostic Imaging Dataset official statistics announcements 2026 ·
• NHS England - National Imaging Registry (NIR) Infrastructure Guidelines 2026 ·
• Care Quality Commission (CQC) Provider Registry ·
• UK Companies House Registry Data